Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-08-071024
Filing Date
2008-12-24
Accepted
2008-12-24 12:10:42
Documents
5
Period of Report
2008-09-30

Document Format Files

Seq Description Document Type Size
1 v134975_10k.htm 10-K 1375311
2 v134975_ex31-1.htm EX-31.1 11884
3 v134975_ex31-2.htm EX-31.2 12824
4 v134975_ex32-1.htm EX-32.1 7948
5 v134975_ex32-2.htm EX-32.2 7505
  Complete submission text file 0001144204-08-071024.txt   1416985
Mailing Address 18 TECHNOLOGY, SUITE 130 IRVINE CA 92618
Business Address 18 TECHNOLOGY, SUITE 130 IRVINE CA 92618 949-336-7111
NURX PHARMACEUTICALS, INC. (Filer) CIK: 0001174228 (see all company filings)

EIN.: 870681500 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-K | Act: 34 | File No.: 000-52037 | Film No.: 081269678
SIC: 2833 Medicinal Chemicals & Botanical Products